LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 45 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $70,000 | -4.1% | 9,559 | +0.3% | 0.00% | – |
| Q4 2020 | $73,000 | +10.6% | 9,533 | +30.7% | 0.00% | – |
| Q3 2020 | $66,000 | +6.5% | 7,294 | -0.9% | 0.00% | – |
| Q2 2020 | $62,000 | +158.3% | 7,358 | +49.7% | 0.00% | – |
| Q1 2020 | $24,000 | -35.1% | 4,916 | -5.5% | 0.00% | – |
| Q4 2019 | $37,000 | -33.9% | 5,201 | +0.3% | 0.00% | – |
| Q3 2019 | $56,000 | -18.8% | 5,185 | -2.5% | 0.00% | – |
| Q2 2019 | $69,000 | +40.8% | 5,316 | +6.4% | 0.00% | – |
| Q1 2019 | $49,000 | -12.5% | 4,997 | -6.6% | 0.00% | – |
| Q4 2018 | $56,000 | – | 5,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Board of Trustees of The Leland Stanford Junior University | 909,244 | $8,984,000 | 1.25% |
| Orbimed Advisors | 6,466,783 | $63,892,000 | 0.99% |
| Lion Point Capital, LP | 500,000 | $4,940,000 | 0.45% |
| Sio Capital Management, LLC | 158,958 | $1,571,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 417,625 | $4,126,000 | 0.38% |
| Redmile Group, LLC | 909,787 | $8,989,000 | 0.26% |
| SAMLYN CAPITAL, LLC | 634,283 | $6,266,000 | 0.15% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 910,000 | $8,991,000 | 0.02% |
| FRANKLIN RESOURCES INC | 700,000 | $6,916,000 | 0.00% |
| UBS Group AG | 47 | $0 | 0.00% |